Physician profile
Brian Howard
NPI 1982832267
$98,702.84
in general payments reported to CMS, 2019-2025
36 companies · $12K in 2025
The $12K reported for 2025 was more than what 79% of Advanced Heart Failure and Transplant Cardiology providers received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,377 · 2020: $617 · 2021: $7,427 · 2022: $6,266 · 2023: $27K · 2024: $43K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $36K · Consulting Fee: $29K · Food and Beverage: $9,291 · Travel and Lodging: $6,160 · Education: $25.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $36,150.00 |
| Consulting Fee | $29,389.00 |
| Food and Beverage | $9,291.21 |
| Travel and Lodging | $6,159.97 |
| Education | $25.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $42,880.85 | 2019-2025 | Barostim Neo System |
| Abiomed | $35,581.01 | 2023-2024 | Impella |
| Abbott Laboratories | $9,414.86 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip, Cardiomems |
| Impulse Dynamics (USA) INC. | $4,343.55 | 2022-2024 | Optimizer, Optimizer |
| Novartis Pharmaceuticals Corporation | $1,323.85 | 2019-2025 | |
| Daxor Corporation | $765.64 | 2023-2024 | Bva-100 |
| Irras USA, INC. | $682.91 | 2024 | |
| Medtronic, INC. | $498.57 | 2023-2024 | Pipeline, Symplicity G3, Cobalt Dr Mri Surescan |
| Astrazeneca Pharmaceuticals LP | $402.70 | 2019-2025 | Farxiga, Wainua |
| Medtronic Vascular, INC. | $375.63 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $308.47 | 2019-2025 | Jardiance |
| Boston Scientific Corporation | $229.03 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $226.62 | 2022-2025 | Lifevest |
| Inari Medical, INC. | $195.80 | 2021 | |
| Pfizer INC. | $185.05 | 2019-2025 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $154.32 | 2021-2025 | Verquvo |
| Procyrion, INC. | $136.28 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $131.51 | 2024-2025 | |
| Asahi Intecc USA, INC. | $125.95 | 2024 | Peripheral Vascular |
| Novo Nordisk INC | $108.66 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Scpharmaceuticals INC. | $107.32 | 2023-2025 | |
| Daiichi Sankyo INC. | $63.05 | 2019-2023 | Injectafer |
| Teleflex LLC | $59.76 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $57.18 | 2019-2025 | Camzyos |
| Lexicon Pharmaceuticals, INC. | $50.68 | 2023-2024 | Inpefa |
| Kestra Medical Technology Services, INC. | $44.01 | 2023-2024 | Assure Wcd |
| W. L. Gore & Associates, INC. | $36.50 | 2021 | |
| Amgen INC. | $35.95 | 2019 | |
| Janssen Pharmaceuticals, INC | $31.13 | 2019-2020 | |
| Bridgebio Pharma, INC. | $23.67 | 2025 | Attruby |
| Actelion Pharmaceuticals US, INC. | $23.45 | 2019 | |
| Cardiac Dimensions, INC. | $23.13 | 2024 | |
| Amarin Pharma, INC. | $20.18 | 2019 | |
| Sanofi-Aventis U.S. LLC | $20.01 | 2019 | |
| United Therapeutics Corporation | $18.97 | 2019 | |
| Vifor Pharma, INC. | $16.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Howard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.